Kunming Pharmaceutical fell against the market

Shanghai and Shenzhen stock markets rebounded on Thursday, with individual stocks generally active In contrast, Kunming Pharmaceutical (600422, stock bar) bucked the market again yesterday on the basis of recent continuous adjustment, ranking in the forefront of the decline in the two financial target stocks on that day Kunming Pharmaceutical Co., Ltd opened at a small low price of 27.50 yuan yesterday After an hour of shock and consolidation after opening, the stock price suddenly plunged After that, it continued to fluctuate downward The lowest price in the session was 25.22 yuan The tail market closed at 25.95 yuan, down 5.70% In terms of volume, a total of 206 million yuan was traded in the stock yesterday, significantly higher than the previous trading days of this week Analysts pointed out that from the perspective of recent trends, Kunming Pharmaceutical once reported trading limits on February 10, 11 and 17, which may be due to certain expectations of the market for the company's extended expansion However, since then, with the disclosure of the company's commitment not to plan major matters such as acquisition in the next three months in the announcement of abnormal stock price fluctuation, the stock's rising enthusiasm has also obviously declined The continuous adjustment in the near future should be regarded as the correction of the optimistic expectation of the company's stock price, which belongs to the normal trend In the medium term, with the rich product layout, the company's excessive dependence on the growth of individual products has improved significantly, and the development trend in the later stage is still good, so it is suggested that investors maintain financing positions.